| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 12/29/2010 | EP1694697B1 Surface-located campylobacter jejuni polypeptides |
| 12/29/2010 | EP1685405B1 Angiogenesis inhibiting molecules and their use in the treatment and diagnosis of cancer |
| 12/29/2010 | EP1673398B1 Multispecific deimmunized cd3-binders |
| 12/29/2010 | EP1599503B1 Endothelial cell specific antibodies and uses thereof |
| 12/29/2010 | EP1539228B1 Novel composition and methods for the treatment of immune related diseases |
| 12/29/2010 | EP1529062B1 Therapeutic use of kremen 1 and 2, inhibitors of the canonical wnt-signal transduction |
| 12/29/2010 | EP1497415B1 Methods for detection or modulation of the interaction of a cytokine receptor with its ligand |
| 12/29/2010 | EP1446157B1 Antibodies for inhibiting blood coagulation and methods of use thereof |
| 12/29/2010 | EP1315519B1 Pharmaceutical compositions and methods useful for treating cancer or liver fibrosis |
| 12/29/2010 | EP1165133B1 Anti-human mitochondrial adenylate kinase isozyme antibody, diagnostic formulation and diagnostic kit for cardiac disease |
| 12/29/2010 | EP1127069B1 Method of making a monomeric beta-form of a prion protein |
| 12/29/2010 | CN1874788B Cd20结合分子 Cd20 binding molecules |
| 12/29/2010 | CN101932608A Antigen-binding constructs |
| 12/29/2010 | CN101932607A Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (pcsk9) |
| 12/29/2010 | CN101932606A Humanized antibodies specific for von willebrand factor |
| 12/29/2010 | CN101932605A Compositions and methods for inhibiting tumor progression |
| 12/29/2010 | CN101932604A Use of ephb4 as a diagnostic marker and a therapeutic target for ovarian cancer |
| 12/29/2010 | CN101932603A Methods of treating bone-loss disorders using a gm-csf antagonist |
| 12/29/2010 | CN101932602A Polypeptides and polynucleotides for artemin and related ligands, and methods of use thereof |
| 12/29/2010 | CN101932593A Methods to stabilize proteins and polypeptides |
| 12/29/2010 | CN101932322A Pharmaceutical composition for treating hepatitis c virus infection comprising hmg-coa reductase inhibitor and bile acid |
| 12/29/2010 | CN101928700A Protein kinase PFTK1 monoclonal antibody and preparation method thereof |
| 12/29/2010 | CN101928347A Anti-carcinoembryonic-antigen (CEA) antibody and application thereof |
| 12/29/2010 | CN101928346A Monoclonal antibody of anti-human tissue kallikrein and preparation method thereof |
| 12/29/2010 | CN101928345A Human source antibody and humanization remolding method thereof |
| 12/29/2010 | CN101928344A Human monoclonal antibodies against cd20 |
| 12/29/2010 | CN101928343A Monoclonal antibodies to the CLFA protein and method of use in treating or preventing infections |
| 12/29/2010 | CN101928334A Preparation method of mouse Ehf polypeptide and antibody thereof |
| 12/29/2010 | CN101928333A Human EIF4H polypeptide and preparation method of antibody thereof |
| 12/29/2010 | CN101928332A Preparation method of Human HNRPA0 polypeptide and antibody thereof |
| 12/29/2010 | CN101927011A Virus inactivation method for solution of globulin |
| 12/29/2010 | CN101144071B A strain of hybridoma capable of stably excreting anti-URG11 monoclonal antibody |
| 12/29/2010 | CA2766565A1 Bispecific antibodies that bind to complement proteins |
| 12/29/2010 | CA2766220A1 Readily isolated bispecific antibodies with native immunoglobulin format |
| 12/29/2010 | CA2766163A1 Method of treating cancer with dll4 antagonist and chemotherapeutic agent |
| 12/29/2010 | CA2764257A1 Pharmaceutical agent |
| 12/28/2010 | US7858844 Non-human transgenic organism comprising transgene coding non-aggregating chromo- or fluorescent Cnidarian chromo- or fluorescent protein; chemiluminescent labels and molecular biology |
| 12/28/2010 | US7858760 Antibodies to protein expressed in prostate cancer |
| 12/28/2010 | US7858759 Modified immunoglobulin targeted to human leukocytes which express B7 protein for use in treatment and prevention of cell proliferative disorders |
| 12/28/2010 | US7858758 Immunoglobulin for use in diagnosis of inflammatory diseases |
| 12/28/2010 | US7858757 Immunoglobulin for detecting fetal red blood cells in maternal blood; diagnosing chromosomal or genetic defects in developing fetus |
| 12/28/2010 | US7858756 Bioassays; kits; ELISA; drug abuse |
| 12/28/2010 | US7858755 Monoclonal antibodies that bind Chemerin polypeptide |
| 12/28/2010 | US7858754 Nel-related protein type 1 antibody |
| 12/28/2010 | US7858753 Immunoglobulins |
| 12/28/2010 | US7858752 Chimeric immunoglobulins for use in diagnosis, prevention and treatment of viral infection |
| 12/28/2010 | US7858751 Peptide fragment of LYVE-1 and antibody against the same |
| 12/28/2010 | US7858750 Antibodies to tumor associated proteins |
| 12/28/2010 | US7858746 recognize selectively both Programmed Death 1 (PD-1) protein and a membrane protein co-existing with PD-1 on a cell membrane, and can transmit a suppressive signal of PD-1; for medical treatment and/or prevention of diseases caused by immune abnormality |
| 12/28/2010 | US7858745 modified deoxycytidine kinase (dCK) mutants with enhanced activity towards nucleoside analogs used in cancer chemotherapy, and delivering the enzymes to specific target cells; specifically delivered to leukemic blast cells |
| 12/28/2010 | US7858738 Synthetic human peptides and pharmaceutical compositions comprising them for the treatment of systemic lupus erythematosus |
| 12/28/2010 | US7858679 Polymeric compositions and related methods of use |
| 12/28/2010 | US7858559 In vitro methods of producing and identifying immunoglobulin molecules in eukaryotic cells |
| 12/28/2010 | US7858359 prokaryotic host cells comprising a library of at least 103 different RNA molecules each having a dicistronic coding region; for screening a larger portion of the immunological repertoire for receptors having a preselected activity |
| 12/28/2010 | US7858329 determining whether a treatment of a disorder with an HDAC inhibitor is to be started/continued or not by determining the level of histone acetylation in the sample using an antibody capable of binding to acetylated histone |
| 12/28/2010 | US7858312 Method of treating bladder and lower urinary tract syndromes |
| 12/28/2010 | US7858095 Method for treating or preventing sclerotic disorders using CD-2 binding agents |
| 12/28/2010 | US7858092 Human Fc domain of immunoglobulin, conjugated to a targeting domain comprising a mutant form of blood factor VII, consisting of a substitution of alanine for lysine, or lysine, binds to tissue factor; cancer, rheumatoid arthritis, atherosclerosis |
| 12/28/2010 | US7858091 Insulin-like growth factor binding protein specific monoclonal antibody for use in diagnosis, prevention and treatment of cell proliferative, inflammatory, autoimmune, muscular and vision disorders |
| 12/28/2010 | US7858090 Fibronectin type III (Fn3) for use as diagnostic and treatment tools in gene therapy; identifying the amino acid sequence of a polypeptide molecule capable of binding to a specific binding partner (SBP) so as to form a polypeptide:SSP complex |
| 12/28/2010 | US7858088 chimeric anti-EGP-2-binding scFv fragment 4D5MOC-A; for treatment of human carcinomas; Pseudomonas exotoxin A |
| 12/28/2010 | US7858087 enhancing the complement mediated cytotoxic activity ofchimeric anti-CD20 monoclonal antibody IDEC-C2B8 (RITUXIMAB) for its target cells by contacting with the antibody; and with a donor complement protein either as fresh plasma/sera or as isolated complement components |
| 12/28/2010 | US7858086 Biopolymer mixture for use in diagnosis, prevention and treatment of acute myeloid leukemia |
| 12/28/2010 | US7858070 fusion propteins; homogeneous purity, and unaltered affinity, and can be produced in high yields without the requirement of extensive purification; stable in serum to allow in vivo applications |
| 12/23/2010 | WO2010148223A2 Anti-vegf antibodies and their uses |
| 12/23/2010 | WO2010148117A1 Therapeutic and diagnostic affinity purified specific polyclonal antibodies |
| 12/23/2010 | WO2010147171A1 Chicken-derived anti-lox-1 antibody |
| 12/23/2010 | WO2010147117A1 Peptide and use thereof |
| 12/23/2010 | WO2010146848A1 An antigenic peptide derived from influenza virus and a method for selecting anti-influenza virus antibody |
| 12/23/2010 | WO2010146550A1 Anti notch-1 antibodies |
| 12/23/2010 | WO2010146511A1 Treatment of overactive bladder |
| 12/23/2010 | WO2010146064A1 Diagnostical use of peroxiredoxin 4 |
| 12/23/2010 | WO2010146059A2 Biomarkers for igf-1r inhibitor therapy |
| 12/23/2010 | WO2010146058A1 Bace1 inhibitory antibodies |
| 12/23/2010 | WO2010145895A1 Compositions containing antibodies for treating cd5+ hla-dr+ b or t cell related diseases |
| 12/23/2010 | WO2010145793A1 Bispecific, tetravalent antigen binding proteins |
| 12/23/2010 | WO2010145792A1 Bispecific antigen binding proteins |
| 12/23/2010 | WO2010115629A3 Amatoxin-armed therapeutic cell surface binding components designed for tumour therapy |
| 12/23/2010 | WO2010094981A3 Antibody therapy |
| 12/23/2010 | WO2010093450A3 Pten phosphorylation-driven restistance to cancer treatment and altered prognosis |
| 12/23/2010 | WO2010034718A8 Recombinant proteins having haemostatic activity and capable of inducing platelet aggregation |
| 12/23/2010 | WO2009097394A3 Methods for modulating a population of myeloid-derived suppressor cells and uses thereof |
| 12/23/2010 | US20100325744 Non-glycosylated recombinant monovalent antibodies |
| 12/23/2010 | US20100324272 Pancreatic cancer genes |
| 12/23/2010 | US20100324271 Phage-displaying single-chain antibody capable of recognizing non-reduced mannose residue |
| 12/23/2010 | US20100324270 Compositions and Methods of Use for Modulators of Polypeptides and Polynucleotides in Treating Breast Cancer and Melanoma |
| 12/23/2010 | US20100324269 Refolding proteins using a chemically controlled redox state |
| 12/23/2010 | US20100324125 Proteins derived from white spot syndrome virus and uses thereof |
| 12/23/2010 | US20100324114 Methods and kits to detect hereditary angioedema type III |
| 12/23/2010 | US20100323954 Chimeric polypeptides and uses thereof |
| 12/23/2010 | US20100323908 Methods and Compositions For Diagnosing Osteoarthritis In A Feline |
| 12/23/2010 | US20100323905 Vhh for the Diagnosis, Prevention and Treatment of Diseases Associated with Protein Aggregates |
| 12/23/2010 | US20100323455 Diagnostic assay for human matrix gla-protein and its use as a biomarker |
| 12/23/2010 | US20100323399 Use of Trail Polypeptides to Treat Cancer |
| 12/23/2010 | US20100323389 Fluorescent imaging with substituted cyanine dyes |
| 12/23/2010 | US20100323377 Biochemical markers for cvd risk assessment |
| 12/23/2010 | US20100323375 Agent and method for diagnosis on the occurrence of alzheimer's disease or the tendency to develop alzheimer's disease |
| 12/23/2010 | US20100323370 Method for determining immune system affecting compounds |
| 12/23/2010 | US20100323366 Methods of Selecting a Dopaminergic Neuron Proliferative Progenitor Cells Using LRP4/CORIN Markers |
| 12/23/2010 | US20100322975 Anti-bacterial Vaccine Compositions |